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Accepted 2 May 2013AbstractObjective: To present the ultrasound and molecular genetic diagnosis of thanatophoric dysplasia type II (TD2).
Case Report: A 35-year-old, primigravid woman was referred to our institution for genetic counseling and amniocentesis at 19 weeks of
gestation because of advanced maternal age and sonographic abnormalities in the fetus. The prenatal ultrasound showed short straight femurs,
prominent forehead, narrow chest, skin edema, short limbs, and cloverleaf skull consistent with the diagnosis of TD2. Amniocentesis revealed a
karyotype of 46,XX. DNA testing for the FGFR3 gene using uncultured amniocytes revealed a heterozygous c.1948A>G, AAG>GAG
transversion leading to a p.Lys650Glu(K650E) mutation in the FGFR3 gene. A prenatal ultrasound at 21 weeks of gestation showed ven-
triculomegaly, cloverleaf skull, straight femurs, micromelia, narrow chest, and pseudoencephalocele with a bulging occipital bone mimicking
encephalocele. The pregnancy was subsequently terminated, and a 480-g malformed fetus was delivered with macrocephaly, depressed nasal
bridge, short upturned nasal tip, hypoplastic midface, frontal bossing, short digits, trident-shaped hands, short limbs, cloverleaf skull, narrow
chest, brachydactyly, nuchal edema, and bulging occipital bone.
Conclusion: A prenatal diagnosis of cloverleaf skull, short limbs, straight femurs, and occipital pseudoencephalocele should include a differ-
ential diagnosis of TD2. A molecular analysis of FGFR3 using uncultured amniocytes is useful for the rapid confirmation of TD2 at prenatal
diagnosis.
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Fig. 1. Prenatal ultrasound at 18 weeks of gestation shows (A) a narrow thorax
and (B) a straight femur.
Fig. 2. DNA testing of FGFR3 shows a heterozygous c.1948A>G,
AAG>GAG transversion leading to a p.Lys650Glu(K650E) mutation,
involving lysine-to-glutamine substitution at codon 650 of FGFR3.
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Thanatophoric dysplasia (TD) is one of the most common
lethal skeletal dysplasias in fetuses and neonates, and has an
estimated prevalence rate of 0.2e0.5/10,000 births [1]. TD has
been subdivided into two types according to the clinical fea-
tures [2e4]. TD type I (TD1) (OMIM 187600) is characterized
by curved femurs, short limbs, and narrow chest with or
without cloverleaf skull. TD type II (TD2) (OMIM 187601) is
characterized by straight femurs, short limbs, narrow chest,
and uniform presence of severe cloverleaf skull. Both TD1 and
TD2 can be associated with additional findings of macro-
cephaly, distinctive facial features, redundant skin fold, bra-
chydactyly, and hypotonia [5]. TD1 and TD2 are caused by
gain-of-function mutations in the fibroblast growth factor re-
ceptor 3 (FGFR3) gene (OMIM 134934), which is mapped to
4p16.3 [6e11].
With the advent of prenatal ultrasound and molecular
technology, TD1 and TD2 can be diagnosed prenatally
[9,10,12e16]. Here, we present our experience with prenatal
ultrasound and molecular genetic diagnosis of TD2 using
uncultured amniocytes at amniocentesis in the 2nd trimester.
Case report
A 35-year-old, primigravid woman was referred to our
institution for genetic counseling and amniocentesis at 19
weeks of gestation because of advanced maternal age and
sonographic abnormalities in the fetus. Her husband was 37
years of age. She and her husband were both healthy and
unrelated, and there was no family history of congenital
malformations. A prenatal ultrasound at 18 weeks of gestation
showed a fetus with a biparietal diameter of 4.2 cm (18.87
weeks), an abdominal circumference of 13.6 cm (19.05
weeks), a femur length of 1.82 cm (15.39 weeks), short
straight femurs, a prominent forehead, a narrow chest, and
skin edema (Fig. 1). A level II ultrasound at 19 weeks of
gestation revealed short limbs, a narrow thoracic cage, and
cloverleaf skull consistent with the diagnosis of TD2.
Amniocentesis revealed a karyotype of 46,XX. The array
comparative genomic hybridization analysis revealed no
genomic imbalance. A DNA testing for the FGFR3 gene using
uncultured amniocytes revealed a heterozygous c.1948A>G,
AAG>GAG transversion leading to a p.Lys650Glu(K650E)
mutation in the FGFR3 gene (Fig. 2). A prenatal ultrasound at
21 weeks of gestation showed a biparietal diameter and an
abdominal circumference equivalent to 21 weeks but a short
femur length of 1.6 cm equivalent to 14 weeks, ven-
triculomegaly, cloverleaf skull, straight femurs, micromelia,
narrow chest, and pseudoencephalocele with a bulging oc-
cipital bone mimicking encephalocele (Fig. 3). The pregnancy
was subsequently terminated, and a 480-g malformed fetus
was delivered with macrocephaly, depressed nasal bridge,
short upturned nasal tip, hypoplastic midface, frontal bossing,
short digits, trident-shaped hands, short limbs, cloverleaf skull,
narrow chest, brachydactyly, nuchal edema, and bulging oc-
cipital bone (Figs. 4e6). X-ray showed cloverleaf skull,pseudoencephalocele, small narrow thorax with horizontal
ribs, platyspondyly, straight femurs, and micromelia (Fig. 7).
Discussion
The present case had a K650E mutation in FGFR3 and was
affected with TD2. In addition to TD1 and TD2, mutations of
FGFR3 have been associated with various skeletal dysplasias
such as achondroplasia (OMIM 100800), hypochondroplasia
Fig. 3. Prenatal ultrasound at 21 weeks of gestation shows (A) cloverleaf skull
with bulging parietal bone and temporal bones (arrows), (B) straight femur,
and (C) occipital pseudoencephalocele.
Fig. 4. Whole body view of the fetus at birth at 21 weeks of gestation.
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syndrome with acanthosis nigricans (OMIM 612247), lacrimo-
auriculo-dento-digital syndrome (OMIM 149730), and
CATSHL (camptodactyly, tall stature, scoliosis, and hearing
loss) syndrome (OMIM 610474). FGFR3, a negative regulator
of bone growth, regulates endochondral ossification by
limiting osteogenesis [17]. Gain-of-function mutations in
FGFR3 activate the negative growth control exerted by FGFR3
kinase [17], enhance osteoclastogenesis and bone resorption,inhibit bone marrow stromal cell proliferation, and promote
osteogenic differentiation but block their mineralization [18].
TD1 has been associated with at least 13 distinct gain-of-
function FGFR3 mutations such as R248C (most common),
S249C, G370C, S371C, Y373C, K650M, J807L, J807G,
J807R(c.2419T>C), J807R(c.2419T>A), J807C(c2421A>T),
J807C(c.2421A>C), and J807W [5]. TD2 has been associated
with only one gain-of-function FGFR3 mutation of K650E
[5,8,10]. TD1 occurs more frequently than TD2. In a review of
91 cases of TD, Wilcox et al [10] reported 74 cases (81.3%) of
TD1 and 17 cases (18.7%) of TD2. An advanced paternal age
effect has been associated with FGFR3 mutations in achon-
droplasia, hypochondroplasia, and TD [19]. The majority of
TD patients have a de novo FGFR3 mutation [5]. Hyland et al
[20] reported a very unusual case of somatic and germline
mosaicism for R248C mutation in FGFR3 in a woman man-
ifesting skeletal dysplasia distinct from TD and giving birth to
a fetus with lethal TD.
Various hypotheses have been raised to explain the adverse
effect of K650E mutation in FGFR3 on skeletal development.
Su et al [21] showed that TD2 FGFR3 activates the tran-
scription factor Stat1 and uses Stat1 as a mediator of growth
retardation in bone development. Bellus et al [22] found that
FGFR3 Lys650 codon is located within the critical region of
Fig. 5. Craniofacial appearance of the fetus at birth. The arrow indicates occipital pseudoencephalocele.
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mutations of A1948G (Lys650Glu) and A1949T (Lys650Met),
result in TD2, and SADDAN (severe achondroplasia with
developmental delay and acanthosis nigricans) and TD1,
respectively, by constitutive activation of the FGFR3 tyrosine
kinase. Lievens and Liboi [23] hypothesized that the K650E
mutation in FGFR3 interferes with the complete maturation of
FGFR3, and the immature TD2-FGFR3 protein activates
Stat1. Guo et al [24] provided evidence that the gain-of-
function of FGFR3 in TD2 is mediated by FGFR3’s kinase
activity and involves the constitutive induction and activation
of Spry2, and activated Spry2 interferes with c-Cbl-mediated
ubiquitination of FGFR3. Shung et al [25] suggested that theFig. 6. Trident hands and bramutant FGFR3 in TD2 causes dysregulation of Sox9 and b-
catenin levels and activity in growth plate chondrocytes.
The peculiar aspect of the present case is the association of
cloverleaf skull with occipital pseudoencephalocele. Jap-A-Joe
et al [26] first reported TD2 with cloverleaf skull and
concomitant parietal meningoencephalocele in an anatomical
specimen. Li et al [27] reported a prenatal diagnosis of TD2
with a large occipital encephalocele in a 2nd trimester fetus.
Martı´nez-Frı´as et al [28] reported TD2 with encephalocele and
holoprosencephaly in a newborn infant and suggested that the
so-called encephalocele in association with TD2 is, in fact,
pseudoencephalocele secondary to intracranial pressure gener-
ated by hydrocephalus and severe cranial skeletal dysplasia.chydactyly of the digits.
Fig. 7. X-ray of the fetus at 21 weeks of gestation. The arrow indicates occipital pseudoencephalocele.
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cloverleaf skull, narrow chest, short limbs, straight femurs,
and central nervous system abnormalities, a prenatal sono-
graphic diagnosis of TD2 can be achieved in the 2nd trimester.
Recently, it has been reported that a noninvasive prenatal
diagnosis of TD2 using cell-free fetal DNA in maternal plasma
by restriction enzyme analysis is possible [29]. However, rapid
detection of the FGFR3 mutation in suspicious TD2 on pre-
natal ultrasound using common mutation sequencing on un-
cultured amniocytes is easier and less expensive than
noninvasive prenatal diagnosis using cell-free fetal DNA as-
says for TD. We suggest that molecular analysis of FGFR3
using uncultured amniocytes is useful for the rapid confirma-
tion of TD2 at prenatal diagnosis.Acknowledgments
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